InsiderClue
← All stocks

Oric Pharmaceuticals, Inc.

ORIC Net selling
CIK 0001796280 #2271 in the set updated 17 Sep 2026
Bought (120 mo)
$12.60M
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$40.61M
$3.57M on a plan · $2.32M straight out of an exercise
Sold at will
$34.72M
89 of 117 sales
Net
−$28.01M
−$22.12M against sales at will

By person

12 insiders · 136 transactions
Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
GORDON CARL L
Director
$4.50M (1)
$15.17M (14)
−$10.67M
2,212,571
2.13%
$30.28M
—
ORBIMED ADVISORS LLC entity
Director
$4.50M (1)
$15.17M (14)
−$10.67M
2,212,571
2.13%
$30.28M
—
Chacko Jacob
PRESIDENT AND CEO
$3.01M (6)
$6.48M (35)
−$3.47M
581,711
0.5612%
$7.96M
+2,619%
Piscitelli Dominic
Chief Financial Officer
$321.62K (1)
$2.76M (17) scheduled
−$2.43M
69,828
0.0674%
$955.66K
+35.9%
Heyman Richard A.
Director
—
$524.42K (20)
−$524.42K
464,798
0.4484%
$6.36M
+17.0%
SCHELLER RICHARD H
Director
—
$275.81K (12)
−$275.81K
39,092
0.0377%
$535.01K
+56.4%
You Angie
Director
$262.90K (2)
—
+$262.90K
28,000
0.0270%
$383.21K
—
Multani Pratik S
Chief Medical Officer
—
$222.56K (4)
−$222.56K
68,149
0.0657%
$932.68K
+215.0%
Topspin Fund L.P. entity
10% owner
—
— (1)
$0.00
2,144,320
2.07%
$29.35M
+94.9%
Svennilson Peter
Director
—
—
—
4,768,181
4.60%
$65.26M
+6,258%
COLUMN GROUP II, LP entity
10% owner
—
—
—
3,568,255
3.44%
$48.83M
—
Kunkel Lori Anne
Director
—
—
—
84,200
0.0812%
$1.15M
—

Individual transactions

8
Insider
Date
Role
Action
Shares
Price
Amount
Kunkel Lori Anne
8 Dec 2025
Director
Exercised, kept
10,000
$7.90
$79.00K
Kunkel Lori Anne
4 Dec 2025
Director
Exercised, kept
5,534
$3.75
$20.75K
Heyman Richard A.
3 Oct 2025
Director
Exercised, kept
1,447
$3.75
$5.43K
Heyman Richard A.
3 Oct 2025
Director
Exercised, kept
31,353
$1.60
$50.16K
Kunkel Lori Anne
3 Mar 2025
Director
Exercised, kept
20,500
$6.33
$129.77K
Kunkel Lori Anne
3 Mar 2025
Director
Exercised, kept
27,666
$3.75
$103.75K
Kunkel Lori Anne
3 Jun 2024
Director
Exercised, kept
20,500
$3.75
$76.88K
COLUMN GROUP II, LP
12 Nov 2021
10% owner
Exercised, kept indirect
16,625
$16.00
$266.00K
Show all 136 transactions →

What was left out

Form 4 filings counted 144
Amendments (4/A) skipped 3
Filings about a different issuer 0
Unreadable filings 0
Joint filings 10
Sales on a Rule 10b5-1 plan 17
Sales straight out of an exercise 11
Sales at will 89
Transactions with no price 1
Shares from compensation/vesting 20,396,870
Sales filed before the plan box existed 76
History held since 27 Apr 2020